NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,239 filers reported holding NOVARTIS A G in Q1 2024. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,238,303 | +9.8% | 21,024 | -0.2% | 1.18% | +10.4% |
| Q1 2024 | $2,037,804 | -2.4% | 21,066 | +1.9% | 1.07% | -9.7% |
| Q4 2023 | $2,087,137 | -3.5% | 20,671 | -2.6% | 1.18% | -7.6% |
| Q3 2023 | $2,162,544 | +7.4% | 21,231 | +6.4% | 1.28% | +5.5% |
| Q2 2023 | $2,014,320 | +11.8% | 19,962 | +2.0% | 1.22% | +7.8% |
| Q1 2023 | $1,800,917 | +3.9% | 19,575 | +2.4% | 1.13% | -0.9% |
| Q4 2022 | $1,733,392 | +21.2% | 19,107 | +1.5% | 1.14% | +7.7% |
| Q3 2022 | $1,430,000 | -7.4% | 18,816 | +3.0% | 1.06% | -1.6% |
| Q2 2022 | $1,544,000 | +0.8% | 18,268 | +4.6% | 1.07% | +10.2% |
| Q1 2022 | $1,532,000 | +6.1% | 17,463 | +5.8% | 0.98% | +5.4% |
| Q4 2021 | $1,444,000 | +10.6% | 16,507 | +3.4% | 0.92% | -1.7% |
| Q3 2021 | $1,306,000 | -9.3% | 15,965 | +1.1% | 0.94% | -8.6% |
| Q2 2021 | $1,440,000 | +8.7% | 15,787 | +1.8% | 1.03% | +0.2% |
| Q1 2021 | $1,325,000 | -7.2% | 15,502 | +2.5% | 1.03% | -14.5% |
| Q4 2020 | $1,428,000 | – | 15,120 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
| MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
| SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
| SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
| SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
| First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
| PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
| GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
| Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
| WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |